Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT04521699

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
  • Mayo Clinic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04521699
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04521699. Randomized; no masking; primary purpose treatment. Start 2022-01-13 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
Acronym
CalmiGo
Intervention (Device)
CalmioGO Stress management device
Lead sponsor
Mayo Clinic (class: other)
Collaborator
CalmiGO (class: not stated)

Record details

Record id
cardio:ct-nct04521699
Content hash
9e5cdeaf8be8007d27472edcc5fe2643e18052239e85013036f1216a5ffee3fe